Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionCasein kinase 1 delta (CSNK1D; CKI-delta) inhibitor
Molecular Target Casein kinase 1 delta (CSNK1D) (CKI-delta)
Mechanism of ActionKinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Neurology (unspecified)
Indication DetailsTreat circadian rhythm disruptions
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today